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B lymphocyte survival, development, and 
function are dependent on signals produced 
by the B cell receptor (BCR), which comprises 
membrane-bound Ig and a dimer of Ig super-
family signal transducers Igα and Igβ (CD79a 
and CD79b) (1–6). Although neither Igα nor 
Igβ has enzymatic function, transfection and 
transgenic mouse experiments showed that the 
cytoplasmic domain of either Igα or Igβ was 
suffi     cient to initiate BCR signaling (7–13). 
Gene targeting revealed that the cytoplasmic 
domains of either Igα or Igβ were not abso-
lutely required for early stages of B cell devel-
opment, but a fully intact BCR was essential 
for complete B cell maturation (14–16) and 
survival in vivo (17).
The Igα-Igβ dimer is noncovalently associ-
ated with membrane Ig through polar residues 
in the transmembrane domain of Ig (10, 11, 
18–21), and it initiates BCR signaling through 
immune receptor tyrosine activation motifs 
(ITAMs) (22). Tyrosine residues imbedded in 
the ITAMs serve as substrates for Src and Syk 
kinases and as a platform for recruiting and or-
ganizing other activated SH2 domain–contain-
ing tyrosine kinases (3–6). Syk has two SH2 
domains, both of which must be engaged by 
the BCR for effi   cient activation (23). Once ac-
tivated, Syk binds cooperatively to the ITAMs 
of Igα and Igβ and phosphorylates downstream 
adaptors and kinases triggering a cascade that 
leads to nuclear eff  ectors (3–6). Syk is an essen-
tial kinase in the BCR pathway. In the absence 
of Syk, there is no BCR signaling in DT40 
cells, and Syk−/− mouse B cells fail to develop 
beyond the pro–B cell stage (24–26).
Despite the importance of the Igα and Igβ 
cytoplasmic domains in initiating BCR signal-
ing and Syk recruitment, loss of either pro-
duced hyperresponsive IgHEL transgenic B cells, 
suggesting an unexpected negative regulatory 
function for Igα and Igβ (16, 27, 28). Experi-
ments with Igα ITAM mutant B cells (IgαFF) 
demonstrated that this unexpected phenome-
non was mediated by Igα ITAM tyrosines, but 
the mechanism of negative regulation by Igα 
was not established (15).
Here we show that Igβ ITAM tyrosines 
modulate ligand-induced signaling by regulat-
ing BCR internalization.
RESULTS
Ig𝗃AA mice
To determine the function of Igβ ITAM ty-
rosines in mature B cells, we replaced these 
residues with alanine residues by gene targeting 
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(Fig. 1 A). Expression of the mutant protein was confi  rmed 
by immunoprecipitation and Western blotting on B cell ly-
sates using antibodies specifi  c for the cytoplasmic domains of 
Igα and Igβ (Fig. 1 B) (29, 30). Mutant Igβ was coimmu  no-
precipitated with Igα and vice versa (Fig. 1 B and Fig. S1 A, 
which is available at http://www.jem.org/cgi/content/full/
jem.20060221/DC1). After BCR cross-linking, Igα was ty-
rosine phosphorylated in both wild-type and mutant B cells 
(Fig. 1 B). In the wild-type, small amounts of phosphotyro-
sine were also found on Igβ in response to receptor cross-
linking, but we found no phosphorylation of mutant Igβ in 
IgβAA B cells (Fig. 1 B and Fig. S1 B). We conclude that 
IgβAA B cells produce the mutant protein and that it is as-
sociated with Igα.
B cell development in Ig𝗃AA mice
We used fl  ow cytometry to examine the eff  ect of the IgβAA 
mutation on B cell development and to compare it with 
IgαFF, in which the ITAM tyrosine residues of Igα were mu-
tated to phenylalanine (15). We found normal numbers of 
pro–B (IgM−B220lowCD25), pre–B (IgM−B220lowCD25+), 
immature B (IgM+B220lowIgD−/low), and recirculating B cells 
(IgM+B220hiIgDhi) in the bone marrow of IgβAA mice 
(Fig. 1 C). The only reproducible diff  erence between devel-
oping B cells in IgβAA and wild-type mice was in the higher 
levels of surface IgM and IgD on immature and recirculating 
B cells (Fig. 1 C).
In the spleen, the number of IgβAA B cells was similar 
to wild-type, as was the proportion of marginal zone 
  (CD21hiCD23lo) and follicular B cells (CD21hiCD23hi) (Fig. 
1 C). This is in contrast to IgαFF mice that appear to have 
fewer marginal zone B cells (Fig. 1 C) (15). In the spleen, as 
in the bone marrow, IgβAA B cells showed higher levels of 
surface IgM and IgD expression than wild-type B cells, but 
normal CD19 levels (Fig. 1, C and D, and not depicted). 
Finally, in the peritoneal cavity, IgβAA mice showed a fi  ve-
fold reduction in the number of B1a B cells similar to that 
found in IgαFF mice (Fig. 1 C) (31–36). Thus, Igβ ITAM 
tyrosines are essential for normal levels of cell surface BCR 
expression but not required for most other aspects of B 
cell development.
To determine whether the combined ITAMs in Igα and 
Igβ were required for B cell development, we crossed IgαFF 
and IgβAA to obtain double mutant mice. We found that 
Figure 1.  Targeting the Ig𝗃 locus. (A) Diagram shows the endog-
enous Igβ locus (top), targeting construct (middle), and the targeted 
locus (bottom). Boxes labeled with roman numerals indicate exons, and 
the transmembrane domain (TM), diagnostic BcgI site, and position of 
alanine (A) substitutions are shown. (B) Purifi  ed splenic B cells from 
wild-type and IgβAA mice were stimulated with anti-IgM, and extracts 
were immunoprecipitated with anti-Igα or anti-Igβ and blotted with 
anti-phosphotyrosine 4G10 antibodies or anti-Igα or anti-Igβ antibodies. 
(C) Flow cytometry analysis of bone marrow, spleen, and peritoneal 
cavity B cells from wild-type, IgαFF, IgαFF/IgβAA, and IgβAA mice. Stain-
ing antibodies are indicated. Numbers show relative percentages of 
cells within indicated gates. (D) Histogram plots show expression of 
surface IgM and IgD by splenic B220+ B cells in wild-type (red) and 
IgβAA (blue) mice.JEM VOL. 203, July 10, 2006  1787
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B cells that express a BCR with no cytoplasmic ITAM tyro-
sine residues fail to develop beyond the pro–B cell stage 
(Fig. 1 C; IgM−B220lowCD25−). We conclude that a single 
intact ITAM in either Igα or Igβ is both necessary and suffi   -
cient for normal B cell development with the exception of 
B1a cells.
Enhanced B cell responses in vivo
IgβAA mutant mice showed a threefold increase in serum IgM 
levels, a fi  vefold decrease in IgG1, normal levels of IgG2a, 
IgG2b, IgG3, and IgA, and no increase in anti-DNA anti-
bodies (Fig. 2 A and not depicted). To determine whether 
IgβAA B cells respond normally to antigen in vivo, we immu-
nized mice with a T-independent antigen 4-hydroxy-3-
  nitrophenylacetyl (NP)-Ficoll or a T-dependent antigen NP 
coupled to chicken γ globulin (NP-CGG) and measured 
anti-NP–specifi  c antibody responses by ELISA (Fig. 2, B–D). 
IgβAA mice showed a 10-fold increase in anti-NP–specifi  c 
IgM, a small increase in IgG3 responses to T-independent 
antigen, no increase in proliferative responses to anti-IgM in 
vitro, and slightly decreased T-dependent antibody responses 
(Fig. 2, B–D, and not depicted). In contrast, there was no ap-
parent diff  erence in antibody responses to the same antigens 
in IgαFF mice (15). We conclude that IgβAA B cells express 
increased levels of surface IgM and are hyperresponsive to 
stimulation with T-independent antigen in vivo.
Decreased BCR internalization
Increased BCR surface expression in IgβAA B cells was not 
due to increased mRNA expression (not depicted). To de-
termine whether the increased surface levels of BCR found 
on IgβAA B cells was associated with altered BCR internaliza-
tion, we measured spontaneous internalization (Fig. 3 A). 
Cell surface BCRs were labeled with monovalent biotin-
ylated Fab′ anti-IgM to avoid receptor cross-linking, incubated 
at 37°C, and visualized with streptavidin. Wild-type B cells 
internalized 30% of their receptors in 20 min, but IgαFF and 
IgβAA internalized only 5–7% of their receptors during the 
same time (Fig. 3 A). Thus, both IgαFF and IgβAA B cells 
were severely impaired in constitutive BCR internalization 
Figure 2.  Steady-state antibody levels and antibody responses. 
Individual wild-type and IgβAA mice are represented by open circles and 
fi  lled triangles, respectively. Bold lines indicate mean values for each group. 
Plots show total serum Ig or relative binding to NP2-BSA. (A) Steady-state 
serum Ig concentrations (μg/ml) in age- and sex-matched wild-type and 
IgβAA mice. (B) IgM response to immunization with NP-Ficoll. (C) IgG3 
response to immunization with NP-Ficoll. (D) IgG1   response to immuniza-
tion with NP-CGG. 
Figure 3.  BCR internalization. (A) Endocytosis. Plots show relative 
rates of BCR internalization by purifi  ed IgαFF, IgβAA, and wild-type B cells 
at 37°C as measured with a biotinylated Fab′ anti-IgM antibody. (B)   Ligand-
mediated internalization. Internalization of a biotinylated F(ab′)2 anti-IgM 
antibody by IgαFF, IgβAA, and wild-type B cells at 37°C. Experiments in A 
and B were repeated three times with similar results. (C) Electron micro-
graphs show BCR labeling on IgβAA and wild-type B cells with 10 nm of 
gold-labeled anti–rabbit antibodies 10 min after cross-linking by Fab′2 
anti-IgM at 37°C.1788  REGULATION OF BCR THRESHOLDS (INTERNALIZATION) BY IGβ | Gazumyan et al.
compared with wild-type. IgβAA B cells were more impaired 
than IgαFF B cells (Fig. 3 A).
To examine BCR internalization in response to BCR 
cross-linking, we incubated B cells with biotinylated F(ab′)2 
anti-IgM. BCR internalization in response to receptor cross-
linking was both decreased and delayed in IgβAA B cells (Fig. 
3, B and C). Although wild-type cells internalized 50% of the 
cell surface BCR in 5 min, IgβAA B cells reached this level of 
BCR internalization only after 20 min. In contrast, IgαFF B 
cells displayed a more modest decrease in receptor internal-
ization in response to cross-linking. They internalized 50% of 
their receptors in 9 min (Fig. 3 B). By ultrastructural analysis, 
wild-type cells (n = 65 cells) internalized 65% of the gold-
  labeled surface-bound F(ab′)2 in 10 min, whereas only 20% 
of the same tracer was internalized by IgβAA B cells (n = 64 
cells) at this time point (Fig. 3 C). Thus, the ITAM tyrosine 
residues in both Igα and Igβ are required for constitutive and 
ligand-mediated BCR internalization. However, the IgβAA 
mutation results in a more profound block in BCR internal-
ization than the IgαFF mutation.
Enhanced Ca2+ responses
To determine whether signaling is aff   ected by the IgβAA 
  mutation, we initially measured Ca2+ fl  ux responses to BCR 
cross-linking with F(ab′)2 anti-IgM antibodies. We found 
that IgβAA B cells showed increased Ca2+ fl  ux responses to 
anti-IgM when compared with wild-type or IgαFF B cells at 
all doses of anti-IgM tested (Fig. 4 A).
To determine whether the enhanced Ca2+ signaling is 
simply the result of increased surface IgM expression by 
IgβAA B cells, we compared Ca2+ responses in wild-type and 
mutant B cells with low (L), medium (M), and high (H) lev-
els of IgM expression (Fig. 4 B). B cells were stained with 
Fab′ anti-IgM and gated based on expression of similar levels 
of surface IgM. Although Ca2+ fl  ux was lower in cells ex-
pressing lower levels of surface IgM (Fig. 4 B, L), direct 
comparison of IgβAA and wild-type B cells expressing equiv-
alent levels of surface IgM showed that Ca2+ fl  ux responses 
were always higher in IgβAA B cells (Fig. 4 B). We conclude 
that IgβAA are hyperresponsive to BCR cross-linking and 
that this eff  ect is not simply due to higher levels of surface 
BCR expression.
Tyrosine phosphorylation
BCR cross-linking leads to phosphorylation of several cellu-
lar substrates. To determine whether tyrosine phosphoryla-
tion responses were altered in IgβAA B cells, we measured 
total cellular tyrosine phosphorylation (Fig. 5 A). Consistent 
with increased Ca2+ fl  ux responses, we found increased and 
prolonged general cellular tyrosine phosphorylation in IgβAA 
B cells compared with wild-type control (Fig. 5 A).
BCR phosphorylation is mediated by Src and Syk family 
kinases. To determine whether Src and Syk activation was 
altered in IgβAA B cells, we measured their phosphorylation 
in responses to BCR cross-linking by Western blotting with 
phospho-Src–specifi  c antibodies (Fig. 5 B) and by immuno-
precipitation with anti-Syk (Fig. 5 C). In contrast to increased 
Ca2+ fl  ux and general tyrosine phosphorylation responses, 
we found a decrease in Src and Syk activation in IgβAA B cells 
(Fig. 5, B and C). In addition, Syk phosphorylation was 
  delayed (Fig. 5 C).
Syk becomes associated with phosphorylated Igα-Igβ 
ITAM tyrosines after BCR cross-linking by a mechanism 
that requires cooperative binding of both of its SH2 domains 
(23, 37). To determine whether this association was altered 
in IgβAA B cells, we immunoprecipitated BCR with anti-Igα 
and immunoblotted it with 4G10 and anti-Syk antibodies. 
Although Iga phosphorylation was marginally reduced (Fig. 1 B 
Figure 4.  Ca2+ fl  ux responses. (A) Ca2+ fl  ux response to BCR cross-
linking with 0.1, 5, and 20 μg/ml anti-IgM in splenic B cells from IgβAA 
(blue), IgαFF (green), and wild-type (red) B cells. Histograms show fl  uores-
cence 405/485 nm ratio of Indo-1-AM emission (y axis) in response to 
BCR cross-linking plotted as a function of time in seconds (x axis). (B) Ca2+ 
fl  ux analysis in response to BCR stimulation in IgβAA (blue) and wild-type 
(red) B cells gated based on similar levels of surface IgM. Top panel shows 
IgM expression by B cells stained with FITC-labeled Fab′ and gating based 
on the level of IgM expression. Bottom panel shows histogram plots of 
Ca2+ fl  ux response to BCR cross-linking with 5 μg/ml Fab′2 anti-IgM on 
the gated populations as indicated by arrows. The time points of anti-IgM 
addition are indicated by small arrows.JEM VOL. 203, July 10, 2006  1789
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and Fig. S1 B), we found decreased association of phos-
phorylated Syk with the BCR in IgβAA B cells after receptor 
cross-linking when compared with wild-type controls de-
spite equivalent levels of cellular Syk expression in wild-type 
and IgβAA B cells (Fig. 5, D and E). BLNK and c-Cbl are 
central adaptor proteins that are directly downstream of Syk. 
Consistent with decreased Syk activation, we found decreased 
BLNK and c-Cbl phosphorylation in IgβAA B cells after BCR 
cross-linking but normal levels of BLNK and c-Cbl expres-
sion (Fig. 5 F and not depicted). We conclude that phos-
phorylation of BCR proximal kinases is impaired but overall 
cellular tyrosine phosphorylation is enhanced and prolonged 
in IgβAA B cells.
Phospholipase C-γ2 (PLC-γ2) amplifi  es  BCR  signals 
by producing second messengers, diacylglycerol and inosi-
toltriphosphate. To determine whether PLC-γ2 activation 
was altered in IgβAA B cells, we measured its phosphorylation 
by immunoblotting with phospho-specifi  c antibodies (Fig. 5 
G). Despite the reduced Syk activity and increased Ca2+ fl  ux 
responses, we found no diff  erence in the level of PLC-γ2 
Figure 5.  Signaling responses. IgβAA or wild-type splenic B cells 
were stimulated with 20 μg/ml F(ab′)2 anti-IgM at 37°C for the indi-
cated times. Anti-actin, anti-Iga, anti-Syk, and anti-JNK antibodies were 
used for loading controls as indicated. (A) Tyrosine phosphorylation of 
total cellular proteins analyzed by immunoblotting with 4G10 antibody. 
(B) Src kinase phosphorylation in total cellular lysates measured by 
immunoblotting with anti–phospho-src–specifi  c antibodies. (C) Syk 
tyrosine phosphorylation analyzed by immunoblotting of anti-Syk 
  immunoprecipitates with 4G10. (D) Association of Syk with the BCR 
and its phosphorylation. Anti-Igα immunoprecipitates were immuno-
blotted with anti-Syk or 4G10 antibody. (E) Cbl-b and Syk levels in total 
cellular lysates were measured by immunoblotting with anti–Cbl-b and 
anti-Syk antibodies. (F) Phosphorylation of BLNK and c-Cbl in total 
cellular lysates measured by immunoblotting with anti–phospho-Cbl or 
anti–phospho-BLNK antibodies. (G) PLC-γ2 and Akt phosphorylation in 
total cellular lysates measured by immunoblotting with anti–phospho-
Akt or anti–phospho-PLC-γ2 antibodies. (H) JNK and ERK phosphoryla-
tion in total cellular lysates measured by immunoblotting with 
anti–phospho-JNK and anti–phospho-ERK. (I) NF-κB activation was 
measured by degradation of the IkB-α subunit in total cell extracts 
using anti–IkB-α antibodies. All experiments were repeated three times 
with similar results.1790  REGULATION OF BCR THRESHOLDS (INTERNALIZATION) BY IGβ | Gazumyan et al.
phosphorylation in the mutant B cells. PI3K is another es-
sential kinase that amplifi   es BCR signaling by producing 
phosphatidylinositol-(3,4,5)-triphosphate. Phosphatidylinositol-
(3,4,5)-triphosphate amplifi   es signaling by recruiting PH 
  domain–containing proteins to the plasma membrane, in-
cluding serine/threonine kinase Akt. Although we were 
unable to detect signifi   cant changes in p85 phosphoryla-
tion by Western blotting, we found that activation of Akt 
was dramatically increased and prolonged in IgβAA B cells 
in response to BCR cross-linking (Fig. 5 G and Fig. S2, 
which is available at http://www.jem.org/cgi/content/full/
jem.20060221/DC1). Therefore, Igβ ITAM mutation en-
hances Akt activation in response to BCR signaling.
Mitogen-activated protein kinases (MAPKs) and NF-κB 
are nuclear eff  ectors of BCR signaling. To determine whether 
MAPK and activation NF-κB were altered in IgβAA B cells, 
we measured phosphorylation of MAPK and NF-κB as well 
as degradation of NF-κB by Western blotting. We found that 
ERK phosphorylation was enhanced and prolonged, but p38, 
JNK, and IκBα phosphorylation as well as NF-κB degra-
dation were not altered (Fig. 5, H and I, and not depicted). 
We conclude that there is a discrepancy between proximal 
and distal signaling responses in IgβAA B cells. Proximal sig-
naling, as exemplifi  ed by Syk activation, is impaired, whereas 
phosphorylation of distal eff  ectors, such as Akt and ERK, is 
enhanced by the same mutation.
Negative regulators of BCR signaling
In addition to activators, BCR signaling is also controlled 
by several negative regulators, including CD72, CD45, 
CD5, FcγRIIb, and CD22 (38). We found no diff  erences 
in the expression levels of the constitutive negative regula-
tors CD72, CD45, and CD5 by fl  ow cytometry (not de-
picted). FcγRIIb was ruled out because all of the signaling 
experiments were performed using F(ab′)2 antibodies and 
because BCR cross-linking with intact and Fab′2 antibody 
had similar eff  ects on IgβAA B cells. CD22 becomes phos-
phorylated by the Lyn kinase in response to BCR cross-
linking (39–42) and terminates BCR signaling by recruiting 
SH2-containing tyrosine phosphatase 1 (SHP-1) and SH2-
containing inositol polyphosphate 5-phosphatase (SHIP) 
(43–45). We found normal levels of CD22 and SHP-1 
phosphorylation after BCR cross-linking in IgβAA B cells 
(Fig. 6, A and B). In addition, association between SHP-1 
and phosphorylated CD22 was unchanged in IgβAA B cells 
as measured by coimmunoprecipitation (Fig. 6 B). Finally, 
SHIP phosphorylation was normal in response to BCR 
cross-linking in IgβAA B cells (Fig. 6 C). Thus, neither CD22 
nor SHIP phosphorylation nor absence of SHP-1  recruitment 
can account for prolonged and enhanced BCR signaling in 
IgβAA B cells.
BCR internalization decreases signaling
Others have shown that BCR internalization can regulate the 
magnitude and duration of signaling as measured by total 
  tyrosine phosphorylation and ERK activation in B cell lines 
(46, 47). To determine whether blocking BCR internaliza-
tion enhances signaling in primary B cells, we partially blocked 
BCR internalization by inhibiting actin polymerization with 
cytochalasin D (Fig. S3 A, available at http://www.jem.org/
cgi/content/full/jem.20060221/DC1). Signaling was mea-
sured by immunoblotting with anti-phospho ERK antibodies 
after receptor cross-linking. We found that 10 μM cytocha-
lasin D inhibited ligand-mediated BCR internalization and 
enhanced ERK phoshorylation, though to a lesser extent than 
IgβAA mutation (Fig. S3 B). Thus, our fi  ndings are consistent 
with the idea that normal termination of BCR signal trans-
duction appears to require BCR internalization (46, 47). 
Activation-induced ubiquitylation
Ubiquitylation regulates the internalization of many cell sur-
face receptors, including the TCR (for review see references 
48 and 49). To determine whether BCR ligation results in its 
ubiquitylation and whether Igβ regulates ubiquitylation, we 
performed Western blotting experiments with anti-  ubiquitin 
antibodies. Wild-type and IgβAA B cells were stimulated with 
F(ab′)2 anti-IgM antibodies, and   ubiquitylation was measured 
Figure 6.  Negative regulators. IgβAA or wild-type splenic B cells were 
stimulated with 20 μg/ml F(ab′)2 anti-IgM at 37°C for the indicated times. 
(A) CD22 tyrosine phosphorylation analyzed by immunoblotting of anti-
CD22 immunoprecipitates with 4G10. Anti-CD22 is shown as a loading 
control. (B) Recruitment of SHP-1 to CD22. Anti–SHP-1 immunoprecipi-
tates were immunoblotted with 4G10 or anti-CD22 antibodies. The posi-
tions of SHP-1 and CD22 are indicated. Anti–SHP-1 immunoblot is shown 
as a loading control. (C) SHIP tyrosine phosphorylation analyzed in cel-
lular lysates by immunoblotting with anti–phospho-SHIP antibodies. 
Anti-actin is shown as a loading control. JEM VOL. 203, July 10, 2006  1791
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on BCRs purifi  ed by immunoprecipitation with anti-Igβ or 
anti-Igα. We found inducible BCR ubiquitylation, and con-
sistent with decreased c-Cbl phosphorylation and reduced 
IgβAA BCR internalization, we found decreased ubiquity-
lation of Igα or Igβ precipitates from IgβAA B cells (Fig. 7 and 
not depicted). We conclude that BCR-  associated proteins are 
ubiquitilated upon receptor ligation and that the Igβ ITAM 
tyrosines are required for normal BCR ubiquitylation.
DISCUSSION
To evaluate how Igβ might regulate BCR signaling, we mu-
tated Igβ ITAM tyrosine residues to alanine. We selected 
the alanine substitution because it destroys phosphorylation 
and internalization motifs, whereas phenylalanine   substitution 
might only interfere with phosphorylation (50). In contrast 
to Igα or Igβ cytoplasmic domain deletion, which altered B 
cell maturation in the periphery (16, 27), B cell development 
in IgαFF and IgβAA mice was nearly indistinguishable from 
wild-type (15). Non-ITAM residues must account for these 
phenotypic diff  erences and may do so by stabilizing or facili-
tating BCR signaling (51–54).
Although IgβAA B cells showed normal distribution of 
most cell surface antigens, they expressed higher levels of 
surface BCRs that were defective in steady-state and ligand-
  mediated endocytosis. The role of Igα and Igβ ITAM ty-
rosine residues in endocytosis was previously studied in cell 
lines using chimeric FcγRIIB receptors (55). In those exper-
iments, Igα was able to mediate endocytosis by a mechanism 
that required an intact ITAM. Consistent with those observa-
tions, we found decreased ligand-mediated receptor internal-
ization in IgαFF mice (Fig. 3) and enhanced internalization in 
Igαα mice whose BCRs carry two Igα cytoplasmic domains 
(56). In contrast to Igα, Igβ was inactive in endocytosis in 
transfection experiments (55). Thus, the observation that the 
IgβAA mutant BCR was profoundly defective in endocytosis 
in B cells in vivo reveals a novel and essential function for 
the Igβ ITAM. In addition, the fi  nding that IgαFF is nearly 
as defective in steady-state endocytosis as IgβAA suggests that 
constitutive ITAM phosphorylation is an important regulator 
of BCR internalization.
The role of Igα and Igβ ITAM tyrosine residues in 
  ligand-mediated BCR internalization was originally studied 
by measuring antigen presentation by B cell lines expressing 
chimeric Ig, Fc, and PDGF receptors by several groups (11, 55, 
57–59). In all cases, both Igα and Igβ were active in ligand-
mediated internalization (11, 55, 57–59). The role of the 
ITAM phosphorylation varied with the experimental system 
and was required in some (59) but not in others (56, 60). Our 
results with IgαFF and IgβAA mice are consistent with a re-
quirement for phosphorylation in ligand-mediated receptor 
internalization in vivo. The diff  erence in the internalization 
phenotype between the two mutants could be due to non-
ITAM residues (51, 52) or to partial preservation of the inter-
nalization signal by the phenylalanine substitution in IgαFF 
(50). In addition, we show that Igβ regulates activation-
  induced ubiquitylation, which may control receptor levels by 
enhancing endocytosis or by targeting surface BCR to the 
degradative lysosomal compartment (48, 49).
IgβAA B cells resembled IgαFF B cells in several important 
ways, including the unexpected fi  nding that both mutants 
showed enhanced Ca2+ and tyrosine phosphorylation re-
sponses to BCR cross-linking (15). The observation that 
IgαFF BCRs were hyperresponsive led to the suggestion that 
a major function of the Igα ITAM was to recruit negative 
regulators (15, 27, 28). This model predicts that Igβ ITAM 
mutation should produce an inactive BCR due to unopposed 
negative regulation by Igα. On the contrary, we found that 
IgβAA BCRs were also hyperactive in vitro and in vivo. IgβAA 
B cells produced enhanced T-independent antibody re-
sponses to NP-Ficoll. Thus, increased BCR signaling in 
IgαFF cannot be due to inability to recruit an Igα-specifi  c 
negative regulator, but must be due to an abnormality in a 
pathway downstream of both Igα and Igβ ITAMs. The en-
hanced responses of IgβAA B cells to BCR cross-linking may 
account for the enhanced T-independent immune responses 
to NP-Ficoll and increased steady-state levels of serum Ig in 
these mice despite the decrease in B1 cells, which together 
with MZ B cells normally produce the majority of circulating 
antibodies in mice. Finally, decreased BCR internalization 
is also consistent with decreased T-dependent immune re-
sponses, which would be dependent on antigen internaliza-
tion and processing for presentation to cognate T cells.
The BCR initiates signal transduction by activation of 
nonreceptor Src and Syk tyrosine kinases. Therefore, it was 
surprising to fi  nd that IgβAA B cells were hyperresponsive to 
BCR stimulation as measured by cellular tyrosine phosphory-
lation and Ca2+ fl  ux, Akt, and ERK activation despite im-
paired Src and Syk family kinase activation. These kinases 
phosphorylate Igα and Igβ, which in turn recruit activated 
Syk by providing docking sites for its two SH2 domains (2–6). 
Our observation of decreased Syk activation and association 
with the IgβAA mutant BCR and decreased BLNK phosphor-
ylation was consistent with the requirement for two functional 
ITAMs for maximal Syk activation (23). Thus, the IgβAA BCR 
is less functional than its wild-type counterpart in activating 
and recruiting proximal nonreceptor tyrosine kinases, but 
Figure 7.  BCR ubiquitylation upon receptor ligation. Wild-type and 
ΙgβAA splenic B cells were stimulated with F(ab′)2 anti-IgM at 37°C for 
the indicated times, and extracts were immunoprecipiated with anti-Igβ 
antibodies. Ubiquitylation was analyzed by immunoblotting with anti-
ubiquitin antibodies. Igα immunoblotting was a loading control.1792  REGULATION OF BCR THRESHOLDS (INTERNALIZATION) BY IGβ | Gazumyan et al.
  paradoxically, this leads to increased Ca2+ fl  ux, Akt, and ERK 
activation, as well as total cellular tyrosine phosphorylation.
Enhanced signaling in the face of decreased Src and Syk 
activation could be due to decreased activation of negative 
regulators, such as CD45, CD72, CD5, FcR, and CD22 (38, 
61). However, we found no abnormalities in any of these 
pathways in IgβAA B cells. CD45, CD72, and CD5 levels 
were all normal, and the involvement of FcγRIIb was ruled 
out by comparing F(ab′)2 and intact antibodies. Negative 
regulation by CD22 is initiated by BCR-mediated activation 
of lyn kinase, which phosphorylates CD22 leading to recruit-
ment of the SHP-1 tyrosine phosphotase to the activated 
BCR (39–45). Although B cells defi  cient in any of the ele-
ments of the CD22 pathway show enhanced BCR signaling 
responses (38, 61), CD22 and SHP-1 phosphorylation and 
SHP-1 recruitment to CD22 were all normal in IgβAA B 
cells. In addition, activation of SHIP, which negatively regu-
lates the BCR by interfering with accumulation of inositol 
phosphate second messengers, was also unaltered in IgβAA B 
cells (62–64). Finally, Cbl-b and c-Cbl are ubiquitin ligases 
that have been implicated as negative regulators of the BCR 
by targeting Syk for degradation by ubiquitinylation (65–67). 
Absence of Cbl-b in mice and overexpression of dominant-
negative c-Cbl in B cell lines lead to enhanced Syk activation 
and signal transduction (66, 68). However, the role of Cbl-b 
and c-Cbl as negative regulators in B cells is debated, and 
they have also been implicated as positive regulators of BCR 
signaling in gene-targeting experiments (68, 69). Although 
there was decreased c-Cbl phosphorylation and a correspond-
ing decrease in BCR-associated ubiquitylation in IgβAA B 
cells, we found no corresponding increase in Syk activation. 
Indeed, Syk phosphorylation was decreased in response to 
BCR ligation. Thus, we cannot attribute the increased BCR 
signaling in IgβAA mutant B cells to alterations in known 
negative regulators, but we cannot rule out eff  ects of yet to 
be defi  ned negative components.
Experiments with inhibitors of tyrosine kinases and phos-
photases have implicated ligand-induced tyrosine phosphory-
lation in regulating BCR internalization (70, 71). How 
phosphorylation activates endocytosis of the BCR has not 
been determined, but several nonmutually exclusive endo-
cytic pathways, including coated pits, rafts, actin, and ubiqui-
tinylation, have been implicated. Blocking BCR endocytosis 
with pharmacologic agents or by deletion of the clathrin 
heavy chain in chicken B cell lines leads to enhanced signal-
ing, suggesting that receptor internalization is an important 
mechanism for attenuating BCR signaling (46, 47). How-
ever, the mechanism by which BCR regulates its internali-
zation was not determined. Our experiments establish a 
molecular link between Igβ, BCR internalization, and ter-
mination of signaling responses in vivo.
MATERIALS AND METHODS
Mice. Igβ cytoplasmic tyrosines 195 and 206 were replaced with alanine by 
gene targeting. The long arm of the targeting vector was 9-kb long with a 3′ 
end at the SpeI site located in the third intron of Igβ (Fig. 1 A). The short 
arm was a 2.5-kb fragment from the SpeI site in the third intron of Igβ to 
the NotI site located 1.8 kb downstream of the termination codon. TAT 
codons at positions 195 and 206 in the cytoplasmic tail were replaced with 
alanines by substitution with GCT. A LoxP-fl  anked neomycin-resistance 
gene was used for positive selection, and a diphtheria toxin gene was used for 
negative selection (72). The targeting construct was linearized with PacI and 
transfected into 129/Sv embryonic stem cells. 100 embryonic stem cell 
clones were screened, three positive clones were injected into C57B/6 blas-
tocysts, and two produced chimeric mice that transmitted the mutation. The 
mutation was confi  rmed by sequencing mRNAs cloned from mutant B cells 
(Fig. S4, available at http://www.jem.org/cgi/content/full/jem.20060221/DC1). 
Heterozygous IgβAA mice were backcrossed to C57BL/6 for two genera-
tions after Cre deletion in the germline before intercrossing. All mice were 
maintained under specifi  c pathogen-free conditions, and experiments were 
performed under Rockefeller University Institutional Animal Care and Use 
Committee–approved protocols.
Flow cytometry. Single cell suspensions from bone marrow, spleen, and 
peritoneal cavity were stained with FITC, PE, APC, and biotin-conjugated 
monoclonal antibodies for 20 min on ice. Biotinylated antibodies were visu-
alized with streptavidin PerCp. The following monoclonal antibodies were 
used: anti-CD43, anti-IgM, anti-B220, anti-CD25, anti-IgD, anti-CD19, 
anti-CD5, anti-CD21, anti-HSA, and anti-CD23 (BD Biosciences). Data 
were collected with a FACSCalibur and analyzed using CellQuest software 
(Becton Dickinson).
Immunizations and ELISA. Age- and sex-matched 8–12-wk-old mice 
were injected intraperitoneally with either 12.5 g NP190-Ficoll or 50 g of 
alum-precipitated NP21-CGG (both from Biosearch Technologies) in 300 μl 
PBS. To measure serum antibody levels, goat anti–mouse Ig (H+L) was used 
for capture and horseradish peroxidase–conjugated goat anti–mouse isotype-
specifi  c antibodies (SouthernBiotech) was used for detection. Values were 
calculated by comparison with mouse Ig standards (SouthernBiotech). To 
measure NP-specifi  c IgM and IgG antibody levels, we used 5 μg/ml NP2BSA 
(Biosearch Technologies) for capture and horseradish peroxidase–conjugated 
goat anti–mouse IgM or anti–mouse IgG for detection (Jackson Immuno-
Research Laboratories). Serial dilutions were performed for each sample, and 
readings were taken within the linear range for each sample and adjusted for 
dilution. Results refl  ect relative absorbance for each sample compared with 
the standard control. All plates were developed using a peroxidase substrate kit 
(Bio-Rad Laboratories), and absorbance was measured at 415 nm.
BCR internalization. To measure endocytosis, splenocytes were pree  quil-
ibrated at 4°C in RPMI 0.5% FBS and incubated with either biotin 
goat anti–mouse IgM Fab′ or goat anti–mouse IgM (Fab′)2. Cells were then 
either fi  xed in 0.5% paraformaldehyde in PBS (To) or incubated at 37°C 
for the indicated times (Tn) before termination with 0.5% paraformaldehyde 
in PBS. Fixed cells were stained with PE-B220 and streptavidin Red 670 
(Invitrogen), and surface BCR expression was determined by fl  ow   cytometry. 
Percent internalization was calculated by the formula [% sIgM(T0)  − 
% sIgM(Tn)]/% IgM(T0) × 100 (Fig. 3 A) or [MFI sIgM(T0) − MFI sIgM(Tn)]/
MFI IgM(T0) × 100 (Fig. S3 A), and the results were comparable. For elec-
tron microscopy, B cells were incubated with 10 μg/ml rabbit anti–mouse 
F(ab′)2 (Jackson ImmunoResearch Laboratories) for 20 min on ice, washed 
twice with PBS 0.5% FBS, and incubated for an additional 30 min on ice 
with a 1:5 dilution of 10 nm gold-labeled goat anti–rabbit IgG (GE Health-
care). Excess reagent was removed by washing cells twice with PBS 0.5% 
FBS. Cells were then either fi  xed with 2.5% glutaraldehyde for time zero or 
incubated for 2, 5, or 10 min at 37°C before fi  xation and processing for 
electron microscopy. 20–30 grids were examined for each time point and 
  labeled cells were photographed.
Ca2+ fl  ux. 5 × 106 spleen cells were incubated with 2 μM Indo-1 AM 
  (Invitrogen) in RPMI 2% FBS for 30 min at 37°C. The cells were washed and 
stained with anti–B220-FITC or PE–anti-B220 and Fab′ FITC goat JEM VOL. 203, July 10, 2006  1793
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anti–mouse IgM at room temperature (Jackson ImmunoResearch Laboratories) 
to determine gating. Fluorescence ratios of Indo-1 emission at 405/485 nm 
were measured on cells gated based on B220 and IgM expression by fl  ow 
  cytometry on a FACSVantage SE (Becton Dickinson). Data were acquired for 
30 s without stimulation, and Ca2+ fl ux was induced by the addition of μ chain-
specifi  c F(ab′)2 goat anti–mouse IgM (Jackson ImmunoResearch Laboratories). 
Data were collected for 500 s and analyzed using FlowJo   (TriStar) software.
Western blotting and immunoprecipitation. B cells were purifi  ed 
from the spleen by negative selection with anti-CD43 magnetic beads 
(MACS; Miltenyi Biotec). Cells were stimulated with 20 μg/ml of F(ab′)2 
fragment goat anti–mouse IgM (Jackson ImmunoResearch Laboratories) at 
37°C and lysed in 50 mM Tris HCl, pH 7.7, 150 mM NaCl, 1% NP-40, 
1 mM EDTA, 1 mM EGTA, 0.1% DOC, 10% glycerol, 1 mM PMSF, 
0.2 mM Na3VO4, and protease inhibitors for Western, or 50 mM Tris HCl, 
pH 7.7, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.1% DOC, 1 mM PMSF, 
and 0.2 mM Na3VO4 for immunoprecipitation. Lysates were incubated for 
15 min on ice, and cellular debris was sedimented at 14,000 rpm for 15 min 
at 4°C. Lysates or immunoprecipitates were resolved on a 4–12% NuPage gel 
(Invitrogen) and transferred onto Immobilon-P membranes (Millipore). 
The following antibodies were used in these experiments: anti-JNK1/2, 
anti-p38, and phosphorylation site-specifi  c antibodies to ERK1/2, JNK1/2, 
p38, BLNK, c-Cbl, Akt, PLC-γ2, Src, IkB-α (112B2), and anti–phospho-
IkB-α (Cell Signaling Technology); anti-ERK1/2 antibodies (Promega); 
anti-Syk (N-19), anti-phBLNK, anti-ubiquitin (P4D1), anti-Cbl-b (H-121), 
anti-Cbl (C-15), and anti-phospho pPI 3-kinase p85α (Tyr 508; Santa Cruz 
Biotechnology, Inc.); anti-phophotyrosine antibody 4G10 and anti-SHIP 
(Upstate Biotechnology); anti-phospho SHIP (StemCell Technologies 
Inc.); anti-  actin (Sigma-Aldrich); SHP-1 and anti-CD22 for IP (BD Bio-
sciences); and Igα, Igβ (10), and anti-CD22 (provided by H. Wortis, Tufts 
University, Boston, MA).
Online supplemented material. Fig. S1 shows Igβ expression and phos-
phorylation in wild-type and mutant B cells. Fig. S2 shows PI3 kinase 
p85 and AKT phosphorylation in wild-type and mutant B cells. Fig. S3 
shows internalization and ERK phosphorylation in cytochalasin D–treated 
cells. Fig. S4 shows Igβ cDNA sequence for wild-type and mutant B 
cells. Figs. S1–S4 are available at http://www.jem.org/cgi/content/full/
jem.20060221/DC1.
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